Literature DB >> 19825105

Schistosomiasis and liver fibrosis.

Z A Andrade1.   

Abstract

Schistosoma mansoni infection invariably results in liver fibrosis of the host. This fibrosis may be represented by small focal areas of chronic inflammation and excess extracellular matrix deposited in periovular granulomas, distributed in variable numbers at the periphery of the portal vein system. This is the outcome of 90% of the infected population in endemic areas. Conversely, a minority of infected individuals develop extensive disease with numerous granulomas along the entire extension of the portal spaces. This latter situation is mainly dependent on special hemodynamic changes created by a heavy worm load, with the subsequent production of numerous eggs and represents a severe form of a peculiar chronic hepatopathy. Thus, host-parasite interactions in schistosomiasis help us to understand a number of important features of liver fibrosis: its initiation and regulation, the significance of accompanying vascular changes, the dynamics of fibrosis formation and regression with antiparasitic treatment; host genetic and immunological contributions, and the pathophysiology of portal hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19825105     DOI: 10.1111/j.1365-3024.2009.01157.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  86 in total

Review 1.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

Review 2.  Macrophage activation governs schistosomiasis-induced inflammation and fibrosis.

Authors:  Luke Barron; Thomas A Wynn
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

3.  Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.

Authors:  Eman Said; Shehta A Said; Wagdi F Elkashef; Nariman M Gameil; Elsayed M Ammar
Journal:  Inflammopharmacology       Date:  2012-01-26       Impact factor: 4.473

4.  Hepatitis B and Schistosoma co-infection in a non-endemic area.

Authors:  J Á Cuenca-Gómez; J Salas-Coronas; A B Lozano-Serrano; J Vázquez-Villegas; M J Soriano-Pérez; M Estévez-Escobar; A Villarejo-Ordóñez; M T Cabezas-Fernández
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-07       Impact factor: 3.267

5.  Comparative study of multiclass classification methods on light microscopic images for hepatic schistosomiasis fibrosis diagnosis.

Authors:  Amira S Ashour; Ahmed Refaat Hawas; Yanhui Guo
Journal:  Health Inf Sci Syst       Date:  2018-08-20

6.  Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.

Authors:  Brian B Graham; Margaret M Mentink-Kane; Hazim El-Haddad; Shawn Purnell; Li Zhang; Ari Zaiman; Elizabeth F Redente; David W H Riches; Paul M Hassoun; Angela Bandeira; Hunter C Champion; Ghazwan Butrous; Thomas A Wynn; Rubin M Tuder
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

7.  Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni.

Authors:  Mohamed H Hegab; Somia H Abd-Allah; Maha S Badawey; Ayman A Saleh; Ashraf S Metwally; Ghada M Fathy; Soad M Nada; Sara A Abdel-Rahman; Amira A Saleh; Amal Fawzy; Mohammed Abu El-Magd
Journal:  J Parasit Dis       Date:  2018-04-23

8.  The role of ST2 and ST2 genetic variants in schistosomiasis.

Authors:  Xin Long; Michelle Daya; Jianping Zhao; Nicholas Rafaels; Huifang Liang; Joseph Potee; Monica Campbell; Bixiang Zhang; Maria Ilma Araujo; Ricardo R Oliveira; Rasika A Mathias; Li Gao; Ingo Ruczinski; Steve N Georas; Donata Vercelli; Terri H Beaty; Kathleen C Barnes; Xiaoping Chen; Qian Chen
Journal:  J Allergy Clin Immunol       Date:  2017-02-09       Impact factor: 10.793

9.  NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways.

Authors:  Minjun Yu; Xiulan Qi; Jose L Moreno; Donna L Farber; Achsah D Keegan
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

10.  Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.

Authors:  Bo-Lin Chen; Jie Peng; Qing-Fu Li; Min Yang; Yuan Wang; Wei Chen
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.